CoChat

Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer's disease

Open access
Guan, Hanjun, Liu, Yinxing, Daily, Abigail, Police, Sara, Kim, Myung‐Hee, Oddo, Salvatore, LaFerla, Frank M., Pauly, James R., Murphy, M. Paul, Hersh, Louis B. · 2009 · Journal of Neuroscience Research
Cited by 81

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

A number of therapeutic strategies for treating Alzheimer's disease have focused on reducing amyloid burden in the brain. Among these approaches, the expression of amyloid β peptide (Aβ)‐degrading enzymes in the brain has been shown to be effective but to date not practical for treating patients. We report here a novel strategy for lowering amyloid burden in the brain by peripherally expressing the Aβ‐degrading enzyme neprilysin on leukocytes in the 3xTg‐AD mouse model of Alzheimer's disease. Through transplantation of lentivirus‐transduced bone marrow cells, the Aβ‐degrading protease neprilysin was expressed on the surface of leukocytes. This peripheral neprilysin reduced soluble brain Aβ peptide levels by ∼30% and lowered the accumulation of amyloid β peptides by 50–60% when transplantation was performed at both young and early adult age. In addition, peripheral neprilysin expression reduced amyloid‐dependent performance deficits as measured by the Morris water maze. Unlike other methods designed to lower Aβ levels in blood, which cause a net increase in peptide, neprilysin expression results in the catabolism of Aβ to small, innocuous peptide fragments. These findings demonstrate that peripherally expressed neprilysin, and likely other Aβ‐degrading enzymes, has the potential to be utilized as a therapeutic approach to prevent and treat Alzheimer's disease and suggest that this approach should be explored further. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jnr.21944

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 81

Metadata

Authors
Guan, H., Liu, Y., Daily, A., Police, S., Kim, M., Oddo, S., LaFerla, F. M., Pauly, J. R., Murphy, M. P., & Hersh, L. B.
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2008-11-19
Volume
87
Issue
6
Pages
1462-1473
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W2073991180
Cited by
81
References
15
FWCI
3.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer's disease. https://app.cochat.ai/papers/10.1002/jnr.21944
The paper
Guan, H., Liu, Y., Daily, A., Police, S., Kim, M., Oddo, S., LaFerla, F. M., Pauly, J. R., Murphy, M. P., & Hersh, L. B. (2009). Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer's disease. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.21944

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.